| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |